Ergothioneine ameliorates metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) by enhancing autophagy, inhibiting oxidative damage and inflammation
Ergothioneine may be a drug with great therapeutic potential for MASLD. Furthermore, this protective effect was mediated through the activation of autophagy.
Authors
- Jing‐Wen Yang (ORCID: https://orcid.org/0000-0002-7031-3446)
- Ying Zou (ORCID: https://orcid.org/0009-0002-1327-8418)
- Xinguo Hou (ORCID: https://orcid.org/0000-0003-2045-1290)
- Qincheng Qiao (ORCID: https://orcid.org/0009-0009-7900-2984)
- Jing Gao (ORCID: https://orcid.org/0000-0002-9445-4892)
- Chenyu Nie
- Yan Shi (ORCID: https://orcid.org/0000-0002-7144-6136)
- Li Chen (ORCID: https://orcid.org/0000-0001-8492-1963)
- Xiaoyu Lv
Institutions
- Shandong University (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Lipids in Health and Disease
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1186/s12944-024-02382-9
- Citations
- 14
- Primary Topic
- Ginseng Biological Effects and Applications
- Type
- article
- Field-Weighted Citation Impact
- 3.27
Funders
- National Natural Science Foundation of China
- Double First Class University Plan